Status Plus




Sexual dysfunction after breast cancer patients after diagnosis and treatment

Salem, H1; Smeda, N1


Introduction and Objectives: The aim of the study was to assess the sexual function changes in breast cancer patients after diagnosis and treatment.

Methods: Included in this study, 600 women who were sexually active and had histology proven breast cancer and also have received treatment for breast cancer. The Body Image Scale (BIS) and the Female Sexual Function Index (FSFI) consists of 19 items constituting six sub scales (desire, arousal, lubrication, orgasm, satisfaction, pain) were anonymously completed by the 600 women in the outpatient clinic of our hospital.

Results: 90% of participants have never spoken with their doctor about this subject. 75 % of the participants resumed sexual activity after treatment, with. 65% of them experienced dyspareunia. Reduction of the sexual desire was reported in 50% of the cases. Female orgasmic disorder and arousal problems were reported respectively by 50% and 40% of the subjects. All patients reported a deterioration of the symptomatology after the various treatments. 80% of the dysfunctions were observed after chemotherapy, 15% after surgery, 10% after radiotherapy; and 5% of the subjects indicated the onset of dysfunctions to have been associated with hormonal therapy.

Conclusions: Breast cancer and its treatment may result in significant sexual dysfunctions that affect the quality of life of women with breast cancer.


Work supported by industry: no.

Go Back